These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 24493300

  • 21. Health related quality of life in adolescents with chronic fatigue syndrome: a cross-sectional study.
    Winger A, Kvarstein G, Wyller VB, Ekstedt M, Sulheim D, Fagermoen E, Småstuen MC, Helseth S.
    Health Qual Life Outcomes; 2015 Jul 03; 13():96. PubMed ID: 26138694
    [Abstract] [Full Text] [Related]

  • 22. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.
    Arch Gen Psychiatry; 2005 Oct 03; 62(10):1157-64. PubMed ID: 16203961
    [Abstract] [Full Text] [Related]

  • 23. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.
    McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garcia-Borreguero D, Blackwelder W, Straus SE.
    JAMA; 2005 Oct 03; 280(12):1061-6. PubMed ID: 9757853
    [Abstract] [Full Text] [Related]

  • 24. Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival.
    Nguyen CB, Alsøe L, Lindvall JM, Sulheim D, Fagermoen E, Winger A, Kaarbø M, Nilsen H, Wyller VB.
    J Transl Med; 2017 May 11; 15(1):102. PubMed ID: 28494812
    [Abstract] [Full Text] [Related]

  • 25. The role of hypocortisolism in chronic fatigue syndrome.
    Nijhof SL, Rutten JM, Uiterwaal CS, Bleijenberg G, Kimpen JL, Putte EM.
    Psychoneuroendocrinology; 2014 Apr 11; 42():199-206. PubMed ID: 24636516
    [Abstract] [Full Text] [Related]

  • 26. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H.
    Am J Med; 2006 Feb 11; 119(2):167.e23-30. PubMed ID: 16443425
    [Abstract] [Full Text] [Related]

  • 27. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD, Shults J, Rutherford N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):100-6. PubMed ID: 17804135
    [Abstract] [Full Text] [Related]

  • 28. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.
    Psychosom Med; 2005 Jan 01; 67(3):433-40. PubMed ID: 15911907
    [Abstract] [Full Text] [Related]

  • 29. Norepinephrine and epinephrine responses to physiological and pharmacological stimulation in chronic fatigue syndrome.
    Strahler J, Fischer S, Nater UM, Ehlert U, Gaab J.
    Biol Psychol; 2013 Sep 01; 94(1):160-6. PubMed ID: 23770415
    [Abstract] [Full Text] [Related]

  • 30. Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial.
    Meeus M, Ickmans K, Struyf F, Hermans L, Van Noesel K, Oderkerk J, Declerck LS, Moorkens G, Hans G, Grosemans S, Nijs J.
    Pain Physician; 2013 Sep 01; 16(2):E61-70. PubMed ID: 23511692
    [Abstract] [Full Text] [Related]

  • 31. B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Fluge Ø, Rekeland IG, Lien K, Thürmer H, Borchgrevink PC, Schäfer C, Sørland K, Aßmus J, Ktoridou-Valen I, Herder I, Gotaas ME, Kvammen Ø, Baranowska KA, Bohnen LMLJ, Martinsen SS, Lonar AE, Solvang AH, Gya AES, Bruland O, Risa K, Alme K, Dahl O, Mella O.
    Ann Intern Med; 2019 May 07; 170(9):585-593. PubMed ID: 30934066
    [Abstract] [Full Text] [Related]

  • 32. Transforming growth factor beta (TGF-β) in adolescent chronic fatigue syndrome.
    Wyller VB, Nguyen CB, Ludviksen JA, Mollnes TE.
    J Transl Med; 2017 Dec 04; 15(1):245. PubMed ID: 29202780
    [Abstract] [Full Text] [Related]

  • 33. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.
    Psychol Med; 2008 Jul 04; 38(7):963-73. PubMed ID: 17803834
    [Abstract] [Full Text] [Related]

  • 34. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U.
    Psychoneuroendocrinology; 2005 Feb 04; 30(2):188-98. PubMed ID: 15471616
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 04; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 36. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders.
    Du YS, Li HF, Vance A, Zhong YQ, Jiao FY, Wang HM, Wang MJ, Su LY, Yu DL, Ma SW, Wu JB.
    Aust N Z J Psychiatry; 2008 Sep 04; 42(9):807-13. PubMed ID: 18696285
    [Abstract] [Full Text] [Related]

  • 37. Plasma leptin in chronic fatigue syndrome and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion.
    Cleare AJ, O'Keane V, Miell J.
    Clin Endocrinol (Oxf); 2001 Jul 04; 55(1):113-9. PubMed ID: 11453960
    [Abstract] [Full Text] [Related]

  • 38. Effects of a continuous low-dose clonidine epidural regimen on pain, satisfaction and adverse events during labour: a randomized, double-blind, placebo-controlled trial.
    Wallet F, Clement HJ, Bouret C, Lopez F, Broisin F, Pignal C, Schoeffler M, Derre E, Charpiat B, Huissoud C, Aubrun F, Viale JP.
    Eur J Anaesthesiol; 2010 May 04; 27(5):441-7. PubMed ID: 20299988
    [Abstract] [Full Text] [Related]

  • 39. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome.
    Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC, Heim C.
    Psychosom Med; 2008 Apr 04; 70(3):298-305. PubMed ID: 18378875
    [Abstract] [Full Text] [Related]

  • 40. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.
    Surapaneni DK, Adapa SR, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S.
    J Ethnopharmacol; 2012 Aug 30; 143(1):91-9. PubMed ID: 22771318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.